|
Atricure, Inc. (ATRC) DCF Valoración
US | Healthcare | Medical - Instruments & Supplies | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
AtriCure, Inc. (ATRC) Bundle
Diseñada para la precisión, nuestra calculadora DCF (ATRC) le permite evaluar la valoración de Atricure, Inc. utilizando datos financieros reales y ofrece una flexibilidad completa para modificar todos los parámetros clave para mejorar las proyecciones.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 230.8 | 206.5 | 274.3 | 330.4 | 399.2 | 462.7 | 536.3 | 621.5 | 720.3 | 834.8 |
Revenue Growth, % | 0 | -10.52 | 32.83 | 20.43 | 20.84 | 15.9 | 15.9 | 15.9 | 15.9 | 15.9 |
EBITDA | -21.5 | -33.6 | -36.9 | -29.5 | -8.1 | -46.3 | -53.6 | -62.1 | -72.0 | -83.5 |
EBITDA, % | -9.32 | -16.27 | -13.43 | -8.93 | -2.03 | -10 | -10 | -10 | -10 | -10 |
Depreciation | 9.4 | 9.5 | 10.4 | 11.7 | 14.8 | 18.3 | 21.2 | 24.5 | 28.4 | 33.0 |
Depreciation, % | 4.06 | 4.62 | 3.81 | 3.54 | 3.71 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 |
EBIT | -30.9 | -43.2 | -47.3 | -41.2 | -22.9 | -64.5 | -74.8 | -86.7 | -100.5 | -116.4 |
EBIT, % | -13.38 | -20.9 | -17.24 | -12.47 | -5.74 | -13.95 | -13.95 | -13.95 | -13.95 | -13.95 |
Total Cash | 81.8 | 244.2 | 119.1 | 121.1 | 137.3 | 231.3 | 268.0 | 310.6 | 360.0 | 417.2 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 28.0 | 23.1 | 33.0 | 42.7 | 52.5 | 56.9 | 65.9 | 76.4 | 88.6 | 102.6 |
Account Receivables, % | 12.15 | 11.21 | 12.04 | 12.92 | 13.15 | 12.29 | 12.29 | 12.29 | 12.29 | 12.29 |
Inventories | 29.4 | 35.0 | 39.0 | 45.9 | 67.9 | 69.2 | 80.2 | 93.0 | 107.8 | 124.9 |
Inventories, % | 12.74 | 16.96 | 14.2 | 13.9 | 17.01 | 14.96 | 14.96 | 14.96 | 14.96 | 14.96 |
Accounts Payable | 14.9 | 12.7 | 18.6 | 19.9 | 27.4 | 29.9 | 34.6 | 40.1 | 46.5 | 53.9 |
Accounts Payable, % | 6.48 | 6.17 | 6.78 | 6.02 | 6.85 | 6.46 | 6.46 | 6.46 | 6.46 | 6.46 |
Capital Expenditure | -12.2 | -5.3 | -9.8 | -16.9 | -42.0 | -25.0 | -29.0 | -33.6 | -38.9 | -45.1 |
Capital Expenditure, % | -5.28 | -2.55 | -3.56 | -5.11 | -10.52 | -5.4 | -5.4 | -5.4 | -5.4 | -5.4 |
Tax Rate, % | -1.98 | -1.98 | -1.98 | -1.98 | -1.98 | -1.98 | -1.98 | -1.98 | -1.98 | -1.98 |
EBITAT | -31.1 | -43.3 | -47.1 | -41.5 | -23.4 | -64.5 | -74.7 | -86.6 | -100.4 | -116.3 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -76.4 | -41.9 | -54.4 | -62.0 | -74.9 | -74.4 | -97.8 | -113.4 | -131.4 | -152.3 |
WACC, % | 11.01 | 11.01 | 11 | 11.01 | 11.01 | 11.01 | 11.01 | 11.01 | 11.01 | 11.01 |
PV UFCF | ||||||||||
SUM PV UFCF | -406.2 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -155 | |||||||||
Terminal Value | -1,725 | |||||||||
Present Terminal Value | -1,023 | |||||||||
Enterprise Value | -1,430 | |||||||||
Net Debt | -10 | |||||||||
Equity Value | -1,420 | |||||||||
Diluted Shares Outstanding, MM | 46 | |||||||||
Equity Value Per Share | -30.66 |
What You Will Get
- Real AtriCure Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for AtriCure, Inc. (ATRC).
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates to fit AtriCure's specific context.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on AtriCure’s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections relevant to AtriCure, Inc. (ATRC).
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility for AtriCure’s financial analysis.
Key Features
- Comprehensive Data: AtriCure’s historical financial statements and pre-filled forecasts.
- Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Results: View AtriCure’s intrinsic value update instantly.
- Intuitive Visual Outputs: Dashboard charts illustrate valuation results and essential metrics.
- Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered AtriCure, Inc. (ATRC) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for AtriCure, Inc. (ATRC)’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for AtriCure, Inc. (ATRC)?
- Accuracy: Utilizes authentic AtriCure financials to ensure precise data.
- Flexibility: Tailored for users to easily test and adjust inputs as needed.
- Time-Saving: Eliminate the complexities of creating a DCF model from the ground up.
- Professional-Grade: Crafted with the precision and usability expected at the CFO level.
- User-Friendly: Intuitive design makes it accessible for users with limited financial modeling skills.
Who Should Use This Product?
- Investors: Accurately estimate AtriCure, Inc.’s (ATRC) fair value before making investment decisions.
- CFOs: Leverage a professional-grade DCF model for financial reporting and analysis related to AtriCure, Inc. (ATRC).
- Consultants: Quickly adapt the template for valuation reports tailored for AtriCure, Inc. (ATRC) clients.
- Entrepreneurs: Gain insights into financial modeling used by leading healthcare companies like AtriCure, Inc. (ATRC).
- Educators: Use it as a teaching tool to demonstrate valuation methodologies applicable to AtriCure, Inc. (ATRC).
What the Template Contains
- Pre-Filled DCF Model: AtriCure’s financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate AtriCure’s profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.